Skip to main content
SpringerLink
Log in

Markers and Immunoprofile of Male Genital Tract Tumors

  • Chapter
  • First Online:
Immunohistochemistry in Tumor Diagnostics

  • 2744 Accesses

Abstract

  1. a.

    Markers for prostatic epithelium:

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Seipel AH, Samaratuga H, Delahunt B, et al. Immunohistochemical profile of ductal adenocarcinoma of the prostate. Virchows Arch. 2014;465(5):559–65.

    Article  CAS  PubMed  Google Scholar 

  2. Perner S, Rupp NJ, Braun M, et al. Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG rearrangement and unfavorable clinical course. Int J Cancer. 2013;132(4):804–12.

    Article  Google Scholar 

  3. Tuffaha M. Phenotypic and genotypic diagnosis of malignancies. Immunohistochmical and molecular approach in tumor diagnosis and detection of minimal residual cancer disease. Weinheim, Berlin: Wiley-VCH-Verlag; 2008.

    Book  Google Scholar 

  4. Jiang Z, Woda BA, Wu CL, Yang XJ. Discovery and clinical application of a novel prostate cancer marker: alpha methylacyl CoA racemase (P504S). Am J Clin Pathol. 2004;122:275–89.

    Article  CAS  PubMed  Google Scholar 

  5. Jiang Z, Iczkowski KA, Woda BA, et al. P504S immunostaining boosts diagnostic resolution of “suspicious” foci in prostatic needle biopsy specimens. Am J Clin Pathol. 2004;121:99–107.

    Article  PubMed  Google Scholar 

  6. Paner G, Luthringer DJ, Amin MB. Best practice in diagnostic immunohistochemistry prostate carcinoma and its mimics in needle core biopsies. Arch Pathol Lab Med. 2008;132:1388–96.

    PubMed  Google Scholar 

  7. Skinnider BF, Oliva E, Young RH, et al. Expression of -methylacyl-CoA racemase (P504S) in nephrogenic adenoma. A significant immunohistochemical pitfall compounding the differential diagnosis with prostatic adenocarcinoma. Am J Surg Pathol. 2004;28:701–5.

    Article  PubMed  Google Scholar 

  8. Gurel B, Ali TZ, Montgomery EA, et al. NKX3.1 as a marker of prostatic origin in metastatic tumors. Am J Surg Pathol. 2010;34(8):1097–105.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Asch-Kendrick RJ, Samols MA, Lilo MT, et al. NKX3.1 is expressed in ER-positive and AR-positive primary breast carcinomas. J Clin Pathol. 2014;67(9):768–71.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Skotheim R, Korkmaz K, Klokk T, et al. NKX3.1 expression is lost in testicular germ cell tumors. Am J Surg Pathol. 2003;163(6):2149–54.

    Article  CAS  Google Scholar 

  11. Nagel S, Ehrentraut S, Tomasch J, et al. Transcriptional activation of prostate specific homebox gene NKX3.1 in subset of T-cell lymphoblastic leukemia (T-ALL). PLoS One. 2012;7(7):e40747.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Tomlins SA, Palanisamy N, Siddiqui J, et al. Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases. Arch Pathol Lab Med. 2012;136:935–46.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kirsten D, Mertz YZ, Sunita R, et al. Molecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model. Neoplasia. 2007;9(3):200–6.

    Article  Google Scholar 

  14. Gopalan A, Leversha MA, Dudas ME, et al. TMPRSS2-ERG rearrangement in dominant anterior prostatic tumors: incidence and correlation with ERG immunohistochemistry. Histopathology. 2013;63(2):279–86.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Yaskiv B, Rubin R, He H, et al. ERG protein expression in human tumors detected with a rabbit monoclonal antibody. Am J Clin Pathol. 2012;138:803–10.

    Article  CAS  PubMed  Google Scholar 

  16. Miettinen M, Wang Z, Sarlomo-rikala M, et al. ERG expression in epithelioid sarcoma-a diagnostic pitfal. Am J Surg Pathol. 2013;37(10):1589–5.

    Article  Google Scholar 

  17. Yonezawa S, Higashi M, Yamada N, et al. Mucins in human neoplasms: clinical pathology, gene expression and diagnostic application. Pathol Int. 2011;61:697–716.

    Article  CAS  PubMed  Google Scholar 

  18. Camparo Ph, Comperat EM. SALL4 is a usefull marker in the diagnostic work-up of germ cell tumors in extra-testicular locations. Virchows Arch. 2013;462(3):337–41.

    Google Scholar 

  19. Rabban JT, Zaloudek CJ. A practical approach to immunohistochemical diagnosis of ovarian germ cell tumours and sex cord-stromal tumours. Histopathology. 2013;62:71–8.

    Article  PubMed  Google Scholar 

  20. Miettinen M, Wang Z, McCue PA, et al. SALL4 expression in germ cell and non-germ cell tumors. A systemic immunohistochemical study of 3215 cases. Am J Surg Pathol. 2014;38(3):410–20.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Cao D, Humphrey PA, Allan RAW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer. 2009;12:2640–51.

    Article  Google Scholar 

  22. Jones TD, Ulbright TM, Eble JN, et al. OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res. 2004;10:8544–7.

    Article  CAS  PubMed  Google Scholar 

  23. Looijenga LHJ, Stoop H, de Leeuw HPJC, et al. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 2003;63:2244–50.

    CAS  PubMed  Google Scholar 

  24. Li X, Wang J, Xu Z, et al. Expression of Sox2 and Oct4 and their clinical significance in human non-small-cell lung cancer. Int J Mol Sci. 2012;13:7663–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Williams AS, Shawwa A, Merrimen J, et al. Expression of OCT-4 and SALL4 in diffuse large B-cell lymphoma. Am J Pathol. 2016;40(7):950–7.

    Article  Google Scholar 

  26. Bahrami A, Ro JY, Ayala AG. An overview of testicular germ cell tumors. Arch Pathol Lab Med. 2007;131:1267–80.

    PubMed  Google Scholar 

  27. Ulbright TM. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol. 2005;18:61–79.

    Article  Google Scholar 

  28. Th M. Ulbright, the most common, clinically significant misdiagnoses in testicular tumor pathology, and how to avoid them. Adv Anat Pathol. 2008;15:18–27.

    Article  Google Scholar 

  29. Goldsmith JD, Pawel B, Goldblum JR, et al. Detection and diagnostic utilization of placental alkaline phosphatase in muscular tissue and tumors with myogenic differentiation. Am J Surg Pathol. 2002;26:1627–33.

    Article  PubMed  Google Scholar 

  30. Nonaka D. Differential expression of SOX2 and SOX17 in testicular germ cell tumors. Am J Clin Pathol. 2009;131(5):731–6.

    Article  PubMed  Google Scholar 

  31. Phi JH, Park SH, Kim SK, et al. Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway. Am J Surg Pathol. 2008;32(1):103–12.

    Article  PubMed  Google Scholar 

  32. Sholl LM, Long KB, Hornick JL. Sox2 expression in pulmonary non-small cell and neuroendocrine carcinomas. Appl Immunohistochem Mol Morphol. 2010;18(1):55–61.

    Article  CAS  PubMed  Google Scholar 

  33. Fraternali-Orcioni G, Falini B, Quaini F, et al. Beta-HCG aberrant expression in primary mediastinal large B-cell lymphoma. Am J Surg Pathol. 1999;23:717–21.

    Article  CAS  PubMed  Google Scholar 

  34. Young RH. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems. Mod Pathol. 2005;18:81–98.

    Article  Google Scholar 

  35. Rey R, Sabourin JC, Venara M, et al. Anti-Müllerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol. 2000;31(10):1202–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Carl-Thiem-Klinikum, Institut für Pathologie, Cottbus, Germany

    Muin S. A. Tuffaha

  2. Vivantes Klinikum Neukölln, Institut für Pathologie, Berlin, Germany

    Hans Guski

  3. Universität Bonn, UKB, Institut für Pathologie, Bonn, Germany

    Glen Kristiansen

Authors
  1. Muin S. A. Tuffaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Guski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Glen Kristiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Tuffaha, M.S.A., Guski, H., Kristiansen, G. (2018). Markers and Immunoprofile of Male Genital Tract Tumors. In: Immunohistochemistry in Tumor Diagnostics. Springer, Cham. https://doi.org/10.1007/978-3-319-53577-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53577-7_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53576-0

  • Online ISBN: 978-3-319-53577-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation